Skip to main content
Premium Trial:

Request an Annual Quote

Warnex to Restructure Debt

NEW YORK (GenomeWeb News) – Warnex said yesterday that it has signed preliminary agreements to restructure all of its outstanding debentures totaling CDN$11,345,000 (US$11,028,000).
The Laval, Quebec-based firm said that as part of the restructuring, it would eliminate the fixed conversion rate of 1.369 contained in the US dollar denominated debentures, which will reduce its principal debt on those from approximately $6.9 million to $5 million. It also plans to convert an aggregate of $1.8 million in principal into common shares of Warnex, which trades on the Toronto Stock Exchange.
"With the combined elements of these agreements, we will reduce the amount owed under the debentures by $5 million, representing a significant improvement to our balance sheet,” Mark Busgang, president and CEO of Warnex, said in a statement.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.